Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
|---|---|---|---|---|---|
| C0006826 | Malignant Neoplasms | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0006111 | Brain Diseases | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0242363 | Islet Cell Tumor | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0023467 | Leukemia, Myelocytic, Acute | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0023794 | Lipoidosis | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0004238 | Atrial Fibrillation | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0005695 | Bladder Neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0007131 | Non-Small Cell Lung Carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0026650 | Movement Disorders | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0020459 | Hyperinsulinism | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0021390 | Inflammatory Bowel Diseases | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0014548 | Epilepsy, Generalized | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0011854 | Diabetes Mellitus, Insulin-Dependent | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0020179 | Huntington Disease | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0600139 | Prostate carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0005684 | Malignant neoplasm of urinary bladder | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0018798 | Congenital Heart Defects | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0015934 | Fetal Growth Retardation | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0017636 | Glioblastoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0020615 | Hypoglycemia | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0376358 | Malignant neoplasm of prostate | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C3887461 | Head and Neck Carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0919267 | ovarian neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0011847 | Diabetes | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0020550 | Hyperthyroidism | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
